161 related articles for article (PubMed ID: 9024869)
1. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).
Laderach D; Cerban F; Motran C; Vottero de Cima E; Gea S
Int J Parasitol; 1996 Nov; 26(11):1249-54. PubMed ID: 9024869
[TBL] [Abstract][Full Text] [Related]
2. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (FIV).
Cerban FM; Motran C; Laderach D; Gea S; Gruppi A; Vottero-Cima E
Acta Trop; 1994 Dec; 58(3-4):337-43. PubMed ID: 7709872
[TBL] [Abstract][Full Text] [Related]
4. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
5. Exoantigens from trypanosoma cruzi contain cruzipain.
Gruppi A; Cerbán FM; Vottero-Cima E
Acta Trop; 1997 Feb; 63(2-3):141-9. PubMed ID: 9088427
[TBL] [Abstract][Full Text] [Related]
6. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
7. Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection.
Cazorla SI; Frank FM; Becker PD; Arnaiz M; Mirkin GA; Corral RS; Guzmán CA; Malchiodi EL
J Infect Dis; 2010 Jul; 202(1):136-44. PubMed ID: 20497050
[TBL] [Abstract][Full Text] [Related]
8. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice.
Guiñazú N; Pellegrini A; Giordanengo L; Aoki MP; Rivarola HW; Cano R; Rodrigues MM; Gea S
Microbes Infect; 2004 Nov; 6(14):1250-8. PubMed ID: 15555530
[TBL] [Abstract][Full Text] [Related]
9. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
Martinez J; Campetella O; Frasch AC; Cazzulo JJ
Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
[TBL] [Abstract][Full Text] [Related]
10. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
[TBL] [Abstract][Full Text] [Related]
11. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
[TBL] [Abstract][Full Text] [Related]
12. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.
Giordanengo L; Guiñazú N; Stempin C; Fretes R; Cerbán F; Gea S
Eur J Immunol; 2002 Apr; 32(4):1003-11. PubMed ID: 11920566
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring.
Giordanengo L; Maldonado C; Rivarola HW; Iosa D; Girones N; Fresno M; Gea S
Eur J Immunol; 2000 Nov; 30(11):3181-9. PubMed ID: 11093133
[TBL] [Abstract][Full Text] [Related]
14. Immune response in mice immunized with acidic antigenic fractions from Trypanosoma cruzi cytosol.
Gea S; Gruppi A; Cerban F; Pistoresi Palencia MC; Vottero-Cima E
Rev Inst Med Trop Sao Paulo; 1992; 34(5):389-94. PubMed ID: 1342100
[TBL] [Abstract][Full Text] [Related]
15. Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice.
Acosta DM; Arnaiz MR; Esteva MI; Barboza M; Stivale D; Orlando UD; Torres S; Laucella SA; Couto AS; Duschak VG
Int Immunol; 2008 Apr; 20(4):461-70. PubMed ID: 18195050
[TBL] [Abstract][Full Text] [Related]
16. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.
Arnholdt AC; Piuvezam MR; Russo DM; Lima AP; Pedrosa RC; Reed SG; Scharfstein J
J Immunol; 1993 Sep; 151(6):3171-9. PubMed ID: 7690795
[TBL] [Abstract][Full Text] [Related]
17. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
Morrot A; Strickland DK; Higuchi Mde L; Reis M; Pedrosa R; Scharfstein J
Int Immunol; 1997 Jun; 9(6):825-34. PubMed ID: 9199965
[TBL] [Abstract][Full Text] [Related]
18. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
[TBL] [Abstract][Full Text] [Related]
19. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
Front Immunol; 2020; 11():565142. PubMed ID: 33162979
[TBL] [Abstract][Full Text] [Related]
20. Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review.
Duschak VG; Couto AS
Curr Med Chem; 2009; 16(24):3174-202. PubMed ID: 19689291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
